GeneDx Investors Face Critical Deadline as Lawsuit Reveals $31 Million Loss on Failed Acquisition

Stamford, Thursday, 18 June 2026.
GeneDx Holdings Corp. investors have until August 3, 2026, to join a class-action lawsuit alleging securities fraud. The case centers on a $31.3 million impairment loss tied to the 2025 acquisition of Fabric Genomics—a deal once touted as transformative but now linked to a 49% stock plunge after missed earnings and misleading disclosures. With multiple law firms leading the charge, this lawsuit could reshape accountability in biotech acquisitions.